Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm

被引：1
|
作者：
Bihari, Chhagan [1 ]
Rastogi, Archana [1 ]
Saxena, Priyanka [2 ]
Kumar, Anupam [3 ]
机构：
[1] Inst Liver & Biliary Sci, Dept Pathol, New Delhi, India
[2] Inst Liver & Biliary Sci, Dept Hematol, New Delhi, India
[3] Inst Liver & Biliary Sci, Dept Res, New Delhi, India
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷 / 08期
关键词：
NICHE;
D O I：
10.1007/s00277-015-2396-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1427 / 1429
页数：3
相关论文
共 50 条
  • [21] Effects of Ruxolitinib on Immune Checkpoint Molecule Expression in JAK2 V617F-Positive Cells
    Fu, Jianzhu
    Cheng, Zhiyong
    Zhang, Lijun
    Wen, Xingchu
    Hao, Jianxue
    CLINICAL LABORATORY, 2024, 70 (10) : 1897 - 1907
  • [22] The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature
    Jeremy Jacobs
    Deva Sharma
    Cindy Vnencak-Jones
    Journal of Thrombosis and Thrombolysis, 2022, 53 : 213 - 217
  • [23] The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature
    Jacobs, Jeremy
    Sharma, Deva
    Vnencak-Jones, Cindy
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (01) : 213 - 217
  • [24] The role of NKG2D ligands MICA and MICB in JAK2 V617F-positive myeloproliferative neoplasms
    Ivanova, Milena
    Tsvetkova, Gergana
    Lessichkova, Spaska
    Gesheva, Nevena
    Hadjiev, Evgueniy
    Shivarov, Velizar
    HLA, 2022, 99 (05) : 549 - 549
  • [25] Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells
    Cheng, Zhiyong
    Fu, Jianzhu
    Liu, Guimin
    Zhang, Lijun
    Xu, Qian
    Wang, Su-yun
    LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 196 - 203
  • [26] Comparison of JAK2 V617F positive and negative myeloproliferative diseases
    Szilvasi, A.
    Andrikovics, H.
    Meggyesi, N.
    Tamaska, J.
    Halm, G.
    Lueff, S.
    Nahajevszky, S.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Tordai, A.
    Masszi, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 379 - 379
  • [27] Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms
    Kucine, Nicole
    Al-Kawaaz, Mustafa
    Hajje, Daher
    Bussel, James
    Orazi, Attilio
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 136 - 139
  • [28] Clinical characteristics of JAK2 V617F positive myeloproliferative diseases
    Andrikovics, H.
    Szilvasi, A.
    Meggyesi, N.
    Tamaska, J.
    Halm, G.
    Lueff, S.
    Nahajevszky, S.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Tordai, A.
    Masszi, T.
    BLOOD REVIEWS, 2007, 21 : S124 - S124
  • [29] JAK2 V617F-positive polycythemia vera accompanied by renal artery stenosis
    Kim, Jae Young
    Woo, In Sook
    Yoo, Sang Hoon
    Bae, Kang Nam
    Kim, Gi Jun
    Jung, Yun Hwa
    BLOOD RESEARCH, 2014, 49 (04) : 283 - 285
  • [30] MINOCA as the first presentation of JAK2 V617F-positive polycythaemia rubra vera
    Rus, M. R. Mohamed
    Suhaimi, A. Mohd
    Zulkufli, M. R.
    Kassim, N. Mohd
    Rozali, N.
    Hussin, F. R.
    Shahril, N. S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 369 : 41 - 41
12345